Clinical Trial Search

Primary: Muscle Mass Via Dual-Energy X-ray Absortiometry (DEXA)Scan Data — 6104.45; 6355.3 grams — p=.318

Primary: Effect of Exercise on Inflammation (C-reactive Protein) — 0.00; 0.05 mg/dL

Primary: Percent Change in Hmax — 27.85; 8.43; -4.91; 16.20 percent change in Hmax

Primary: Change in Motor Evoked Potential (MEP) Amplitude in the Tibialis Anterior Muscle at the End of Training. — -1.75; -2.01 Amplitude percentage of Mmax

Primary: Graded and Redefined Assessment of Strength, Sensibility and Prehension Test (GRASSP Test) — 4.5; 19.4 score change before and after — p=<0.000

Primary: 10-meter Walking Speed (m/Sec) — 0.165; 0.215; 0.13; 0.13 speed (m/sec)

Primary: Gait Speed With 10-Meter Walk Test — -10.24; -1.79 seconds — p=0.006

Primary: Incidence of Treatment-emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 5; 4; 5; 6 Participants

Primary: Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS — 0.31; 0.43; 0.45; 0.65 millivolts (mV)

Primary: Change From Baseline in American Spinal Injury (ASIA) Upper Extremities Motor Score — 15.58; 12.63 Scores on a scale — p=0.55

Primary: Muscle Weakness — 2; 3 Participants

Primary: Feasibility of Intraoperative Contrast-enhanced Ultrasound in Acute Traumatic Spinal Cord Injury - Number of Participants With Successful Intraoperative…

Primary: Dual Energy X-ray Absorptiometry (DXA) Assessment of Lean Tissue Mass (LTM) — 53.1; 50.5 kilograms — p=<0.01

Primary: Change in Walking Function - 10m Walk Walking Speed (m/s) — 0.06; 0.16 speed difference in meters per second

Primary: Acute Gene Regulation: MSTN — 5.49; 4.76 arbitrary units — p=<0.001

Primary: Acute Gene Regulation: NR4A3 mRNA Expression Pre and Post-Stimulation — 3.235; 2.711; 6.286; 5.772 arbitrary units — p=<0.001

Primary: Number of Participants Demonstrating 10% Change: Arm Ergometer and Lokomat Metabolic Cart VO2 Peak — 17; 13; 17; 12 participants

Primary: Bone Mineral Density (BMD) of the Total Hip as Assessed by Dual-energy X-ray Absorptiometry (DXA) — 6.73; -0.34; 4.24 Percent change

Primary: Seated Systolic Blood Pressure — 86; 100.4; 102.7; 101.3 mmHg

Primary: Brief Pain Inventory, Worst Pain — 8.9; 9.7 score on scale

Primary: Bladder Storage — 278.5; 447.75; 580.5; 313.0 mLH2O

Primary: Effectiveness of Expiratory Muscle Activation to Generate Large Airway Pressures Characteristic of Normal Cough. — 25; 121 cmH2O — p=<0.05

Primary: Mean Arterial Blood Pressure in Response to Epidural Stimulation — 112.5 mmHg

Primary: Electromyographic Responses (Active)

Primary: 10 Meter Walk Time — -5.0; -4.9; -4.6; -5.5 Seconds

Primary: Change in Visual Analog Scale (VAS) Score From Baseline to 2 Week Post Initial Fitting. — 35 participants with > 50% VAS improvement

Primary: Standing Performance — 27.4; 15.6 minutes

Primary: American Spinal Injury Association (ASIA) Total Score at the Fourth Follow-up — 183.88 score

Primary: Change From Baseline in Exercise Capacity at 6 Months — 14.6; 18.5; 17.1; 13.9 ml/kg/min

Primary: Changes of Neurological Scores for Baseline — -0.158; 0; 2.208; -0.766 units on a scale — p=0.343